menu

Antibody Discovery

Target to Custom Therapeutic-Quality
Antibody Leads in 10-12 Weeks

The powerful Invenra mAb Discovery Engine produces optimized antibody sequences, delivering desired binding properties, developability, and functional validation in the time it takes conventional Immunization campaigns to complete the first step.

10-Week Delivery | Proven Process | Transparent Pricing | Advanced Design

Accelerate Your Antibody Discovery Program

Get Started

 

Traditional Discovery Is Holding Your Program Back

Invenra mAb Discovery

It’s time to consider replacing conventional antibody discovery using animal immunization with a faster and more versatile approach.  The innovative Invenra antibody design service optimizes the timeline, removing three to five months while allowing you to:

  • Achieve desired binding properties
  • Replace slow, hard-to-control approaches with the faster, more reliable platform
  • Eliminate time-consuming humanization studies
  • Target specific properties from the start
  • Stop deferring functional validation to later — more expensive — project stages
  • Know the price up front

The Invenra Advanced Ab Discovery Engine Delivers Unmatched Flexibility

Maximizing lead quality, epitope diversity, and developability from day one, the Invenra antibody discovery platform delivers projects faster and with less risk than conventional approaches.

The Invenra Advantage

  • 30+ proprietary phage display libraries, each with >1 billion unique primary clones
  • Multi-library architecture eliminates single-library bias and expands epitope coverage
  • All libraries are built on clinically validated human germline frameworks, optimizing developability and human-likeness
  • Campaigns simultaneously deploy >90 parallel screens against your target, designed specifically for your desired outcome

Proven Performance

Performance

Proven Process Ensures Project Success

Invenra Discovery Process Steps

Buying Made Easy: Fully Transparent Pricing and Business Terms

Service Tiers

  • Invenra abolishes the gates, back-and-forth emails, and confusing terms, making working with us a seamless and, dare we say, a pleasant experience.
  • Need a number for your budget or grant, you can select the model that fits your requirements, use the numbers below for planning, and reach out when you are ready to go.
  • Let us know your approximate project timing and we will hold a slot for you.

Limited Time Offer*

Get full mAb discovery solution and full data package for $100,000—a value of up to $399,000—in exchange for our right to binders you do not select for your project. This offer provides up to $299,000 in savings!

All Partnership Projects initiated with full payment by December 31, 2026 are eligible for this limited time offer. Partnership projects are subject to Invenra approval.

Select from Six Modalities to Tune Your Antibody Leads

Selection Modes

Our antibody selection modes align precisely with your program goals—whether you need broad, diverse early-stage panels, ultra-high-affinity binders, or candidates targeting specific functional epitopes for mono- or multispecific development.

By incorporating advanced capabilities like cross-reactivity screening and conditional binding selection, we help you de-risk development, ensure translational relevance, and unlock differentiated therapeutic mechanisms tailored to your target biology.

Ready to Accelerate Your Discovery Program? 

To get started, please provide some information about your project requirements: